Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer

Figure 2

Overall survival after surgery for 240 patients with T2 gastric cancer (A) and 165 patients with T3/T4 gastric cancer (B) according to the existence of hyperfibrinogenemia. The group with hyperfibrinogenemia (>310 mg/dl) showed a significantly lower survival rate than another group (≤310 mg/dl) in T2 cancer. There was no statistically significant survival difference in T3/T4 cancer according to the plasma fibrinogen level.

Back to article page